Alzheimer’s disease psychosis (ADP)
Join a study exploring potential treatments with a new class of investigational medication.
Do you or a loved on have Alzheimer’s disease and are experiencing delusions and/or hallucinations?
A clinical trial is enrolling adults aged 55-90 with Alzheimer’s disease psychosis
(ADP)
To pre-qualify for this study, participants must:
Be 55 to 90 years of age.
Have been diagnosed with possible or probable Alzheimer’s disease and are experiencing moderate to severe psychotic symptoms (delusions and/or hallucinations).
Have a care partner who can report on symptoms and medication adherence.